BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15176054)

  • 1. Prostein expression is highly restricted to normal and malignant prostate tissues.
    Kalos M; Askaa J; Hylander BL; Repasky EA; Cai F; Vedvick T; Reed SG; Wright GL; Fanger GR
    Prostate; 2004 Aug; 60(3):246-56. PubMed ID: 15176054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of prostein, a novel prostate-specific protein.
    Xu J; Kalos M; Stolk JA; Zasloff EJ; Zhang X; Houghton RL; Filho AM; Nolasco M; Badaró R; Reed SG
    Cancer Res; 2001 Feb; 61(4):1563-8. PubMed ID: 11245466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue-specific vaccine candidate.
    Friedman RS; Spies AG; Kalos M
    Eur J Immunol; 2004 Apr; 34(4):1091-101. PubMed ID: 15048720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tomoregulin for radioimmunotherapy of prostate cancer.
    Zhao XY; Schneider D; Biroc SL; Parry R; Alicke B; Toy P; Xuan JA; Sakamoto C; Wada K; Schulze M; Müller-Tiemann B; Parry G; Dinter H
    Cancer Res; 2005 Apr; 65(7):2846-53. PubMed ID: 15805286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family.
    Kiessling A; Weigle B; Fuessel S; Ebner R; Meye A; Rieger MA; Schmitz M; Temme A; Bachmann M; Wirth MP; Rieber EP
    Prostate; 2005 Sep; 64(4):387-400. PubMed ID: 15761874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ILK as a potential marker gene to ascertain specific adenocarcinoma cell mRNA isolation from frozen prostate biopsy tissue sections.
    Kieffer N; Schmitz M; Plançon S; Margue C; Huselstein F; Grignard G; Dippel W; Nathan M; Giacchi S; Scheiden R
    Int J Oncol; 2005 Jun; 26(6):1549-58. PubMed ID: 15870868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient sera.
    Day CH; Fanger GR; Retter MW; Hylander BL; Penetrante RB; Houghton RL; Zhang X; McNeill PD; Filho AM; Nolasco M; Badaro R; Cheever MA; Reed SG; Dillon DC; Watanabe Y
    Oncogene; 2002 Oct; 21(46):7114-20. PubMed ID: 12370833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z; Wenlv S
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
    Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD
    Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of N-linked human glycoproteomic data sets reveals PTPRF ectodomain as a novel plasma biomarker candidate for prostate cancer.
    Whitmore TE; Peterson A; Holzman T; Eastham A; Amon L; McIntosh M; Ozinsky A; Nelson PS; Martin DB
    J Proteome Res; 2012 May; 11(5):2653-65. PubMed ID: 22494190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel prostate cancer-associated tumor antigen.
    Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC
    Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a serum tumor marker for preclinical trials of mouse prostate cancer models.
    Huizen IV; Wu G; Moussa M; Chin JL; Fenster A; Lacefield JC; Sakai H; Greenberg NM; Xuan JW
    Clin Cancer Res; 2005 Nov; 11(21):7911-9. PubMed ID: 16278416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate.
    Weigle B; Fuessel S; Ebner R; Temme A; Schmitz M; Schwind S; Kiessling A; Rieger MA; Meye A; Bachmann M; Wirth MP; Rieber EP
    Biochem Biophys Res Commun; 2004 Sep; 322(1):239-49. PubMed ID: 15313197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of monoclonal antibodies against phosphatidylethanolamine binding protein 1 in pancreatic cancer patients.
    Wang X; Wang S; Tang X; Zhang A; Grabinski T; Guo Z; Hudson E; Berghuis B; Webb C; Zhao P; Cao B
    J Immunol Methods; 2010 Oct; 362(1-2):151-60. PubMed ID: 20869966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of a new marker PCA-1 in human prostate carcinoma.
    Konishi N; Nakamura M; Ishida E; Shimada K; Mitsui E; Yoshikawa R; Yamamoto H; Tsujikawa K
    Clin Cancer Res; 2005 Jul; 11(14):5090-7. PubMed ID: 16033822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
    Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
    J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.